Last €24.00 EUR
Change Today 0.00 / 0.00%
Volume 0.0
PUS On Other Exchanges
As of 2:16 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

pulsion medical systems-reg (PUS) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/20/15 - €24.10
52 Week Low
03/3/14 - €17.62
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

pulsion medical systems-reg (PUS) Related Businessweek News

No Related Businessweek News Found

pulsion medical systems-reg (PUS) Details

PULSION Medical Systems SE, together with its subsidiaries, develops, manufactures, and sells systems to monitor, diagnose, and manage the physical parameters of seriously ill and intensive care patients worldwide. The company also produces and markets intravenous diagnostics and sterile disposable items used to monitor patients. It operates in two business units, Critical Care and Perfusion. The company offers PiCCO2 platform, which is used in intensive medical care for treating critically ill patients; PulsioFlex platform that provides technology for use in perioperative medicine; and PiCCO catheter that enables doctors and medical practitioners to monitor the cardiovascular systems of intensive care patients, and to manage the selected therapy. It also provides ProAQT technology, which is used on high-risk patients and during high-risk procedures primarily in the operating room; CeVOX technology that monitors oxygen balance; and LiMON technology to evaluate and monitor liver function. In addition, the company offers ICG PULSION, which is injected into the circulatory system to allow superficial vessels to be visualized; and Photodynamic Eye, a camera unit that is used in various surgical areas. PULSION Medical Systems SE was founded in 1990 and is headquartered in Feldkirchen, Germany.

130 Employees
Last Reported Date: 08/13/14
Founded in 1990

pulsion medical systems-reg (PUS) Top Compensated Officers

Chief Executive Officer and Member of Adminis...
Total Annual Compensation: €476.0K
Compensation as of Fiscal Year 2013.

pulsion medical systems-reg (PUS) Key Developments

Maquet And PULSION Announce Distribution Agreement For The PiCCO(R) And ProAQT(R) Hemodynamic Product Lines

Maquet Medical Systems announced a collaboration with PULSION Medical Systems wherein Maquet will distribute PULSION's PiCCO hemodynamic monitoring technology and ProAQT perioperative hemodynamic management products. Nearly 1,000 publications worldwide have confirmed the accuracy and clinical benefit of the PiCCO technology. The PiCCO Technology provides all the necessary information in an easy to interpret graphical visualization, providing clinicians with tools to assist them make therapeutic decisions, based on clear and hard facts. ProAQT visualizes the arterial blood pressure curve providing clinicians with a decision support tool to determine the patient's cardiovascular status and to support decisions regarding clinical interventions. PiCCO Cardiac Output System monitors hemodynamic function in intensive care situations where using standard monitoring parameters such as ECG, non-invasive blood pressure and pulse oximetry do not provide enough information to enable adequate treatment. The PiCCO Technology provides all the necessary information in an easy to interpret graphical visualization that enables faster therapeutic decisions, based on an array of hemodynamic measurements. ProAQT sensor supports goal directed therapy and allows the review of interventions to assess their success. The ProAQT monitoring range has been expanded to include variables such as blood flow, volume responsiveness, afterload and contractility. ProAQT Sensor is a special single-use cardiac output sensor, designed for continuous hemodynamic monitoring with suitable PULSION monitors. The arterial blood pressure curve is utilized to determine the patient's cardiovascular status and to support decisions regarding clinical interventions.

PULSION Medical Systems SE, Special/Extraordinary Shareholders Meeting, Aug 14, 2014

PULSION Medical Systems SE, Special/Extraordinary Shareholders Meeting, Aug 14, 2014. Agenda: To consider the domination and profit and loss transfer agreement.

PULSION Medical Systems SE Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Fiscal 2014

PULSION Medical Systems SE announced consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported sales were EUR 8.955 million against EUR 9.454 million a year ago. EBITDA was EUR 2.872 million against EUR 3.151 million a year ago. EBIT was EUR 2.396 million against EUR 2.751 million a year ago. Group net profit attributable to shareholders of the group parent company was EUR 882 million against EUR 1.838 million a year ago. Earnings per diluted share were EUR 0.11 against EUR 0.22 a year ago. Cash flow from operating activities after changes in net working capital was EUR 2.870 million against EUR 1.036 million a year ago. Operating profit was EUR 2.415 million against EUR 2.722 million a year ago. Profit before taxes (EBT) was EUR 2.404 million against EUR 2.766 million a year ago. Acquisition of purchased and internally generated intangible assets was EUR 211 million against EUR 174 million a year ago. Purchase of property, plant and equipment (without monitors) was EUR 24 million against EUR 142 million a year ago. For 2014, the company forecast a sales increase in the range of 4% - 6%. This growth is based on expectations, that mutual distribution agreements with the Getinge Group can be closed in the second quarter over the distribution of several product lines in different regions. At the level of the operating result, the company forecast an EBIT margin ­ adjusted for exceptional items ­ within a range of 26% - 28%.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PUS:GR €24.00 EUR 0.00

PUS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Deltex Medical Group PLC 3.63 GBp +0.125
Edwards Lifesciences Corp $133.02 USD -1.88
Hospira Inc $87.54 USD 0.00
ICU Medical Inc $88.91 USD -0.15
LiDCO Group PLC 12.50 GBp 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation PUS Industry Range
Price/Earnings 24.0x
Price/Sales 4.2x
Price/Book 7.5x
Price/Cash Flow 24.1x
TEV/Sales 4.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PULSION MEDICAL SYSTEMS-REG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at